Wait, We Inject Antibiotics Into Eggs for Organic Chicken?!

Which came first: the organic chicken or the gentamicin injection? <a href="http://www.shutterstock.com/pic-133136477/stock-photo-hands-in-blue-gloves-inject-red-liquid-into-egg-isolated-on-white.html?src=pd-same_artist-134562845-An_J0-NhxhY2EIb82W9kdw-1">Sergey Yechikov</a>/Shutterstock

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


When you’ve covered a topic long enough, you get the idea you’ve heard it all. Then along comes a factoid like the one I discovered while preparing my recent piece on the recent blockbuster Consumer Reports study on supermarket chicken and antibiotic-resistant bacteria. I learned that at the industrial hatcheries that churn out chicks for the poultry industry, eggs are commonly injected with tiny amounts of an antibiotic called gentamicin, which is used in people to treat a variety of serious bacterial infections.

To sterilize the small hole required to get a vaccine into an egg, the industry commonly shoot in a bit of gentamicin.

That alone dropped my jaw—what, the practice of dosing chickens with antibiotics has to begin literally in the egg? But get this: The practice is allowed in organic production, too. Organic code forbids use of antibiotics in animals, yet in a loophole I’d never heard of, such standards kick in on “the second day of life” for chicks destined for organic poultry farms. (The practice isn’t used for the eggs we actually eat—just the ones that hatch chicks to be raised on farms.)

John Glisson, a veterinarian for the US Poultry & Egg Association, told me the practice originated decades ago, when the industry began vaccinating chicken embryos to prevent a common condition called Marek’s disease, a deadly herpes virus that attacks chickens. To sterilize the small hole required to get the vaccine into the egg, the industry would shoot in a bit of gentamicin. Glisson added that it remains a common practice, but that it has declined in recent years as (he insisted) the industry has begun to move away from reliance on antibiotics. Neither Glisson nor the FDA could give me precise data on how often it’s used these days. The Food and Drug Administration allows such injections only when prescribed by a veterinarian, a spokesperson said.

So what’s the problem with giving chickens a little antibiotic boost as they start life? For starters, the practice could promote the spread of antibiotic-resistant superbugs. A 2007 peer-reviewed study of Maryland and Virginia workers in conventional chicken houses were 32 times more likely to carrying gentamicin-resistant E. coli than their neighbors who don’t work in the industry.

And Robert Martin, director of food system policy at Johns Hopkins’ Center for a Livable Future, expressed skepticism that cleaning up after a vaccine is the only function of the practice. He said that while he was heading up the Pew Commission on Industrial Animal Production back in 2007, he visited an industrial hatchery and witnessed the injections take place. “During the commission study [completed in 2008], we learned that virtually every egg is injected with very small doses of gentamcin before they go in the incubator,” he said. In addition to sterilizing the egg, he pointed to another possible benefit of the injections—that they “probably aid in rapid growth of the chick in the egg”—i.e., growth promotion, one of the reasons industrial-scale livestock producers have been relying on antibiotics for decades.

So why the loophole in organic? Bob Scowcroft, a veteran of organic-policy debates and now-retired founder of the Organic Farming Research Foundation, explained to me that back in 1990, when the Organic Foods Production Act was crafted, organic chicken production barely existed—and there were certainly no organic hatcheries. It never occurred to anyone to require that chicks come from special hatcheries, he said—such a rule would have crippled the industry from the start. “It was a chicken-and-egg thing,” he quipped.

The “no antibiotics” label, on the other hand, actually means no antibiotics—even before the second day of life.

Since then, as the organic-chicken market has boomed, there seems to have been little push to change the second-day-of-life loophole. I contacted the USDA’s Agricultural Marketing Service about the matter. Congress would need to amend the Organic Foods Production Act of 1990 to remove the exception.

That no one has tried to force such a change to strikes me as odd. In field crops, organic code requires farmers to use organically grown seeds “when commercially available.” That provision has given rise to a still small, but robust and growing, organic seed market. The rise of organic seeds is crucial to the future of organic farming, because plant strains adapted to heavy chemical use and monocrops don’t always do well in diversified, low-input systems, as organic-seed expert Matthew Dillon never tires of pointing out. But until Congress adds a similar “when commercially available” requirement for organically raised chicks, it’s hard to imagine an organic-hatchery sector developing.

Nevertheless, change does appear to be afoot in the industry. Poultry behemoth Perdue, most known for its conventional chicken, is also the nation’s No. 1 organic chicken producer, through its Coleman Natural, Rosie, and Draper brands, company spokesperson Julie DeYoung told me. And those brands source their chicks from company-owned hatcheries that use no antibiotics, she said. The reason has to do not with the organic label, but rather with another USDA-regulated label, the “raised without antibiotics” tag, which also adorn the Perdue organic brands. (In its conventional operations, DeYoung told me, Perdue has over the past five years removed antibiotics from 80 percent of its hatcheries.)

Back in 2008, the USDA determined that Perdue’s rival chicken giant Tyson had been abusing that label by subjecting eggs on hatcheries to gentamicin injections. Since then, any chicken brandishing that label can’t have ever been subjected to the controversial drug, not even in the egg. That is, “no antibiotics” means no antibiotics—even before the second day of life. So on this narrow point, the relatively new “no antibiotics” label has more teeth than the older and more formidable organic stamp.

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate